40
Participants
Start Date
May 31, 2010
Primary Completion Date
May 5, 2016
Study Completion Date
May 5, 2016
Botulinum Toxin Type A
"A vial of Botulinum Toxin A containing 100U of Botox will be reconstituted with 2mL of normal saline for a concentration of 50U/mL.~5 units (0.1mL) of Botulinum Toxin a will be injected at midline and 1.5cm lateral to midline, bidirectionally, following a thyroidectomy or parathyroidectomy."
Normal Saline
0.1mL of normal saline in a placebo vial containing 2mL of normal saline will be injected along three sites (midline and 1.5cm lateral from midline) following a thyroidectomy or parathyroidectomy.
Queen Elizabeth II Hospital, Halifax
Collaborators (1)
Allergan
INDUSTRY
Nova Scotia Health Authority
OTHER